| Mono‐dispersed bioactive glass nanospheres: preparation and effects on biomechanics of mammalian cells Z Hong, GM Luz, PJ Hampel, M Jin, A Liu, X Chen, JF Mano Journal of Biomedical Materials Research Part A 95 (3), 747-754, 2010 | 71 | 2010 |
| Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice PJ Hampel, W Ding, TG Call, KG Rabe, SS Kenderian, TE Witzig, ... Leukemia & lymphoma, 2019 | 52 | 2019 |
| Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre PJ Hampel, MC Larson, B Kabat, TG Call, W Ding, SS Kenderian, ... British journal of haematology 183 (3), 421-427, 2018 | 45 | 2018 |
| CLL update 2022: A continuing evolution in care NE Kay, PJ Hampel, DL Van Dyke, SA Parikh Blood Reviews 54, 100930, 2022 | 36 | 2022 |
| How cholesterol regulates endothelial biomechanics Z Hong, MC Staiculescu, P Hampel, I Levitan, G Forgacs Frontiers in Physiology 3, 29794, 2012 | 29 | 2012 |
| Chronic lymphocytic leukemia treatment algorithm 2022 PJ Hampel, SA Parikh Blood cancer journal 12 (11), 161, 2022 | 22 | 2022 |
| Disease flare during temporary interruption of ibrutinib therapy in patients with chronic lymphocytic leukemia PJ Hampel, TG Call, KG Rabe, W Ding, E Muchtar, SS Kenderian, ... The Oncologist 25 (11), 974-980, 2020 | 21 | 2020 |
| Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis E Muchtar, AB Koehler, MJ Johnson, KG Rabe, W Ding, TG Call, JF Leis, ... American journal of hematology 97 (1), 90-98, 2022 | 20 | 2022 |
| Incidental Richter transformation in chronic lymphocytic leukemia patients during temporary interruption of ibrutinib PJ Hampel, HJJ Cherng, TG Call, W Ding, M Khanlari, ED McPhail, ... Blood Advances 4 (18), 4508-4511, 2020 | 19 | 2020 |
| Incidence and risk of tumor lysis syndrome in patients with relapsed chronic lymphocytic leukemia (CLL) treated with venetoclax in routine clinical practice AB Koehler, N Leung, TG Call, KG Rabe, SJ Achenbach, W Ding, ... Leukemia & Lymphoma 61 (10), 2383-2388, 2020 | 19 | 2020 |
| Outcomes of endoscopic intervention for overt GI bleeding in severe thrombocytopenia GP Ramos, M Binder, P Hampel, MBB Neto, D Sunjaya, B Al Bawardy, ... Gastrointestinal endoscopy 88 (1), 55-61, 2018 | 18 | 2018 |
| Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findings PJ Hampel, KG Chaffee, RL King, D Simonetto, MC Larson, S Achenbach, ... American journal of hematology 92 (12), 1362-1369, 2017 | 18 | 2017 |
| Influence of membrane cholesterol and substrate elasticity on endothelial cell spreading behavior Z Hong, I Ersoy, M Sun, F Bunyak, P Hampel, Z Hong, Z Sun, Z Li, ... Journal of biomedical materials research Part A 101 (7), 1994-2004, 2013 | 17 | 2013 |
| Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosis SA Parikh, KG Chaffee, MC Larson, PJ Hampel, TG Call, W Ding, ... Haematologica 103 (6), e237, 2018 | 16 | 2018 |
| Combined ibrutinib and venetoclax for treatment of patients with ibrutinib‐resistant or double‐refractory chronic lymphocytic leukaemia PJ Hampel, KG Rabe, TG Call, W Ding, JF Leis, SS Kenderian, E Muchtar, ... British journal of haematology 199 (2), 239-244, 2022 | 10 | 2022 |
| Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia PJ Hampel, SA Parikh, TG Call, MV Shah, NN Bennani, A Al-Kali, ... Blood cancer journal 11 (3), 47, 2021 | 8 | 2021 |
| Addition of venetoclax at time of progression in ibrutinib-treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare PJ Hampel, TG Call, W Ding, E Muchtar, SS Kenderian, Y Wang, JF Leis, ... American journal of hematology 95 (3), E57-E60, 2020 | 8 | 2020 |
| Rapid progression of disease following ibrutinib discontinuation in patients with chronic lymphocytic leukemia. PJ Hampel, KG Chaffee, W Ding, T Call, S Kenderian, E Muchtar, JF Leis, ... Journal of Clinical Oncology 36 (15_suppl), 7525-7525, 2018 | 8 | 2018 |
| Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib PJ Hampel, KG Rabe, TG Call, W Ding, JF Leis, AA Chanan-Khan, ... Blood cancer journal 12 (9), 124, 2022 | 7 | 2022 |
| P651: Venetoclax-based treatment of patients with richter syndrome: Outcomes from a multicenter retrospective study P Hampel, S Parikh, W Wierda, A Ferrajoli, N Jain, J Burger, T Call, ... HemaSphere 6, 549-550, 2022 | 7 | 2022 |
